Global Thrombopoietin Receptor Agonist Market Research Report 2023

December 2023 | 66 pages | ID: G92E59B79E09EN
QYResearch

Abstracts

Thrombopoietin receptor agonists have been established as the most significant in the treatment of immune thrombocytopenia purpura (ITP), a disorder in which there is a shortage of blood cells called platelets.

According to QYResearch’s new survey, global Thrombopoietin Receptor Agonist market is projected to reach US$ 1718.7 million in 2029, increasing from US$ 1657 million in 2022, with the CAGR of 0.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Thrombopoietin Receptor Agonist market research.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Thrombopoietin Receptor Agonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Amgen
• Novartis
• Rigel Pharmaceuticals

Segment by Type

• Peptide Agent
• Small Molecule Agent

Segment by Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Thrombopoietin Receptor Agonist report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Thrombopoietin Receptor Agonist Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Peptide Agent
  1.2.3 Small Molecule Agent
1.3 Market by Application
  1.3.1 Global Thrombopoietin Receptor Agonist Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Thrombopoietin Receptor Agonist Market Perspective (2018-2029)
2.2 Thrombopoietin Receptor Agonist Growth Trends by Region
  2.2.1 Global Thrombopoietin Receptor Agonist Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Thrombopoietin Receptor Agonist Historic Market Size by Region (2018-2023)
  2.2.3 Thrombopoietin Receptor Agonist Forecasted Market Size by Region (2024-2029)
2.3 Thrombopoietin Receptor Agonist Market Dynamics
  2.3.1 Thrombopoietin Receptor Agonist Industry Trends
  2.3.2 Thrombopoietin Receptor Agonist Market Drivers
  2.3.3 Thrombopoietin Receptor Agonist Market Challenges
  2.3.4 Thrombopoietin Receptor Agonist Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Thrombopoietin Receptor Agonist Players by Revenue
  3.1.1 Global Top Thrombopoietin Receptor Agonist Players by Revenue (2018-2023)
  3.1.2 Global Thrombopoietin Receptor Agonist Revenue Market Share by Players (2018-2023)
3.2 Global Thrombopoietin Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thrombopoietin Receptor Agonist Revenue
3.4 Global Thrombopoietin Receptor Agonist Market Concentration Ratio
  3.4.1 Global Thrombopoietin Receptor Agonist Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Thrombopoietin Receptor Agonist Revenue in 2022
3.5 Thrombopoietin Receptor Agonist Key Players Head office and Area Served
3.6 Key Players Thrombopoietin Receptor Agonist Product Solution and Service
3.7 Date of Enter into Thrombopoietin Receptor Agonist Market
3.8 Mergers & Acquisitions, Expansion Plans

4 THROMBOPOIETIN RECEPTOR AGONIST BREAKDOWN DATA BY TYPE

4.1 Global Thrombopoietin Receptor Agonist Historic Market Size by Type (2018-2023)
4.2 Global Thrombopoietin Receptor Agonist Forecasted Market Size by Type (2024-2029)

5 THROMBOPOIETIN RECEPTOR AGONIST BREAKDOWN DATA BY APPLICATION

5.1 Global Thrombopoietin Receptor Agonist Historic Market Size by Application (2018-2023)
5.2 Global Thrombopoietin Receptor Agonist Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Thrombopoietin Receptor Agonist Market Size (2018-2029)
6.2 North America Thrombopoietin Receptor Agonist Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Thrombopoietin Receptor Agonist Market Size by Country (2018-2023)
6.4 North America Thrombopoietin Receptor Agonist Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Thrombopoietin Receptor Agonist Market Size (2018-2029)
7.2 Europe Thrombopoietin Receptor Agonist Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Thrombopoietin Receptor Agonist Market Size by Country (2018-2023)
7.4 Europe Thrombopoietin Receptor Agonist Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Thrombopoietin Receptor Agonist Market Size (2018-2029)
8.2 Asia-Pacific Thrombopoietin Receptor Agonist Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Thrombopoietin Receptor Agonist Market Size by Region (2018-2023)
8.4 Asia-Pacific Thrombopoietin Receptor Agonist Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Thrombopoietin Receptor Agonist Market Size (2018-2029)
9.2 Latin America Thrombopoietin Receptor Agonist Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Thrombopoietin Receptor Agonist Market Size by Country (2018-2023)
9.4 Latin America Thrombopoietin Receptor Agonist Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Thrombopoietin Receptor Agonist Market Size (2018-2029)
10.2 Middle East & Africa Thrombopoietin Receptor Agonist Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Thrombopoietin Receptor Agonist Market Size by Country (2018-2023)
10.4 Middle East & Africa Thrombopoietin Receptor Agonist Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Amgen
  11.1.1 Amgen Company Detail
  11.1.2 Amgen Business Overview
  11.1.3 Amgen Thrombopoietin Receptor Agonist Introduction
  11.1.4 Amgen Revenue in Thrombopoietin Receptor Agonist Business (2018-2023)
  11.1.5 Amgen Recent Development
11.2 Novartis
  11.2.1 Novartis Company Detail
  11.2.2 Novartis Business Overview
  11.2.3 Novartis Thrombopoietin Receptor Agonist Introduction
  11.2.4 Novartis Revenue in Thrombopoietin Receptor Agonist Business (2018-2023)
  11.2.5 Novartis Recent Development
11.3 Rigel Pharmaceuticals
  11.3.1 Rigel Pharmaceuticals Company Detail
  11.3.2 Rigel Pharmaceuticals Business Overview
  11.3.3 Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Introduction
  11.3.4 Rigel Pharmaceuticals Revenue in Thrombopoietin Receptor Agonist Business (2018-2023)
  11.3.5 Rigel Pharmaceuticals Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Thrombopoietin Receptor Agonist Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peptide Agent
Table 3. Key Players of Small Molecule Agent
Table 4. Global Thrombopoietin Receptor Agonist Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Thrombopoietin Receptor Agonist Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Thrombopoietin Receptor Agonist Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Thrombopoietin Receptor Agonist Market Share by Region (2018-2023)
Table 8. Global Thrombopoietin Receptor Agonist Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Thrombopoietin Receptor Agonist Market Share by Region (2024-2029)
Table 10. Thrombopoietin Receptor Agonist Market Trends
Table 11. Thrombopoietin Receptor Agonist Market Drivers
Table 12. Thrombopoietin Receptor Agonist Market Challenges
Table 13. Thrombopoietin Receptor Agonist Market Restraints
Table 14. Global Thrombopoietin Receptor Agonist Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Thrombopoietin Receptor Agonist Market Share by Players (2018-2023)
Table 16. Global Top Thrombopoietin Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombopoietin Receptor Agonist as of 2022)
Table 17. Ranking of Global Top Thrombopoietin Receptor Agonist Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Thrombopoietin Receptor Agonist Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Thrombopoietin Receptor Agonist Product Solution and Service
Table 21. Date of Enter into Thrombopoietin Receptor Agonist Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Thrombopoietin Receptor Agonist Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Thrombopoietin Receptor Agonist Revenue Market Share by Type (2018-2023)
Table 25. Global Thrombopoietin Receptor Agonist Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Thrombopoietin Receptor Agonist Revenue Market Share by Type (2024-2029)
Table 27. Global Thrombopoietin Receptor Agonist Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Thrombopoietin Receptor Agonist Revenue Market Share by Application (2018-2023)
Table 29. Global Thrombopoietin Receptor Agonist Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Thrombopoietin Receptor Agonist Revenue Market Share by Application (2024-2029)
Table 31. North America Thrombopoietin Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Thrombopoietin Receptor Agonist Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Thrombopoietin Receptor Agonist Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Thrombopoietin Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Thrombopoietin Receptor Agonist Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Thrombopoietin Receptor Agonist Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Thrombopoietin Receptor Agonist Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Thrombopoietin Receptor Agonist Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Thrombopoietin Receptor Agonist Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Thrombopoietin Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Thrombopoietin Receptor Agonist Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Thrombopoietin Receptor Agonist Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Thrombopoietin Receptor Agonist Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Thrombopoietin Receptor Agonist Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Thrombopoietin Receptor Agonist Market Size by Country (2024-2029) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Thrombopoietin Receptor Agonist Product
Table 49. Amgen Revenue in Thrombopoietin Receptor Agonist Business (2018-2023) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Thrombopoietin Receptor Agonist Product
Table 54. Novartis Revenue in Thrombopoietin Receptor Agonist Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Rigel Pharmaceuticals Company Detail
Table 57. Rigel Pharmaceuticals Business Overview
Table 58. Rigel Pharmaceuticals Thrombopoietin Receptor Agonist Product
Table 59. Rigel Pharmaceuticals Revenue in Thrombopoietin Receptor Agonist Business (2018-2023) & (US$ Million)
Table 60. Rigel Pharmaceuticals Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Thrombopoietin Receptor Agonist Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Thrombopoietin Receptor Agonist Market Share by Type: 2022 VS 2029
Figure 3. Peptide Agent Features
Figure 4. Small Molecule Agent Features
Figure 5. Global Thrombopoietin Receptor Agonist Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Thrombopoietin Receptor Agonist Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Thrombopoietin Receptor Agonist Report Years Considered
Figure 12. Global Thrombopoietin Receptor Agonist Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Thrombopoietin Receptor Agonist Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Thrombopoietin Receptor Agonist Market Share by Region: 2022 VS 2029
Figure 15. Global Thrombopoietin Receptor Agonist Market Share by Players in 2022
Figure 16. Global Top Thrombopoietin Receptor Agonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombopoietin Receptor Agonist as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Thrombopoietin Receptor Agonist Revenue in 2022
Figure 18. North America Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Thrombopoietin Receptor Agonist Market Share by Country (2018-2029)
Figure 20. United States Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Thrombopoietin Receptor Agonist Market Share by Country (2018-2029)
Figure 24. Germany Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Thrombopoietin Receptor Agonist Market Share by Region (2018-2029)
Figure 32. China Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Thrombopoietin Receptor Agonist Market Share by Country (2018-2029)
Figure 40. Mexico Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Thrombopoietin Receptor Agonist Market Share by Country (2018-2029)
Figure 44. Turkey Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Thrombopoietin Receptor Agonist Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Amgen Revenue Growth Rate in Thrombopoietin Receptor Agonist Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Thrombopoietin Receptor Agonist Business (2018-2023)
Figure 48. Rigel Pharmaceuticals Revenue Growth Rate in Thrombopoietin Receptor Agonist Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed